Prostate Cancer Clinical Trial
Official title:
True NTH Sexual Recovery Intervention for Prostate Cancer Survivors and Their Partners
There is increasing evidence that sexual activity is associated with greater resilience and
higher well-being in older adults. Even at a time of stress, and even during a late stage of
illness, men and their partners turn to sexual intimacy to increase a sense of connection,
comfort and support. The Sexual Recovery intervention seeks to address an unmet need of
prostate cancer survivors and their partners who are at risk for poor mental health and
decreased quality of life as a result of sexual dysfunction.
By using technology, the intervention will be widely accessible to survivors, the majority of
whom do not currently have any access to sexual health expertise. The content and format of
the intervention seeks to empower prostate cancer survivors and partners with knowledge and
strategies to improve their sexual function, sexual confidence and their sexual relationship.
The intervention begins prior to and continues following their definitive treatment. This
may, in turn, improve mental health and quality of life.
In a broader sense, this intervention will be transferable. With appropriate modifications,
it can become an accessible sexual health intervention for populations dealing with other
cancers and chronic illnesses.
This proposal is innovative in a number of ways:
- The intervention is based on a full understanding of the complex nature of sexuality
with its bio- (functional), psycho- (confidence), and social (relationship components).
It incorporates modules that address each of these factors and their inter-dependencies.
- The intervention is sensitive to critical points in sexual recovery and to patient and
partner preferences in the context of therapies for prostate cancer. The intervention
acknowledges that there are certain time points at which concerns typically arise (e.g.,
when preparing for definitive treatment). The effectiveness of the intervention is
increased by the use of tailoring linked to patient reported outcomes (e.g., decreased
erectile function, increases in depression indices) and to patient/partner preferences.
- The intervention includes partners as equal stakeholders in the sexual recovery and
legitimizes their needs for sexual fulfillment and support
- The intervention demonstrates a sensitivity to sexual orientation and cultural diversity
- The intervention is scalable and available at limited or no cost to prostate cancer
survivors and their partners regardless of geographical location or system of care.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
| Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
| Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
| Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
| Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
| Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
| Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
| Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
| Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
| Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
| Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
| Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
| Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
| Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |